foxo4-dri peptide senolytic 2023 Computational design of peptide targeting

The telomere research behind Epithalon is peer-reviewed and real, but it requires honest context: telomerase activation is both the mechanism of action and a reason for careful patient selection in certain clinical histories

BMC Syst

- -, , , (3 )

Adequate protein intake, resistance training, and proper supplementation during treatment all contribute to maintaining lean mass

Cerebrolysin demonstrates superior performance in acute ischemic stroke models, with Phase IV clinical trials showing measurable cognitive improvements at 30ml daily IV for 21 days in post-stroke patients, and rodent MCAO (middle cerebral artery occlusion) studies documenting 1825% reductions in infarct volume